The comparative efficacy and safety of basiliximab and antithymocyte globulin in deceased donor kidney transplantation: a multicenter cohort study

BACKGROUND: Generally, an induction agent is chosen based on the conditions of the deceased donor and the recipient. Antithymocyte globulin (ATG) is preferred in relatively high-risk conditions. No clear evidence indicates which induction agent is safer or more efficient for deceased donor kidney tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Su Yeon, Kim, Young Soo, Jin, Kyubok, Han, Seungyeup, Yang, Chul Woo, Chung, Byung Ha, Park, Woo Yeong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Nephrology 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902729/
https://www.ncbi.nlm.nih.gov/pubmed/36747359
http://dx.doi.org/10.23876/j.krcp.21.159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902729/
https://www.ncbi.nlm.nih.gov/pubmed/36747359
http://dx.doi.org/10.23876/j.krcp.21.159

Ejemplares similares